Develop diagnostic tests that identify the unique properties of each patients’ cancer to inform on how best to manage their disease.
Qualisure Diagnostics has raised $361K in total funding. The most recent round was Convertible Note. The last funding was announced in November 2022.
Qualisure Diagnostics's investors include UCeed, Leva Capital.
Qualisure Diagnostics is headquartered in Calgary, Canada.
Develop diagnostic tests that identify the unique properties of each patients’ cancer to inform on how best to manage their disease.
Qualisure Diagnostics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Qualisure Diagnostics — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/qualisure-diagnostics. Accessed August 15, 2026.
VCBacked. (2022). Qualisure Diagnostics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/qualisure-diagnostics
{{cite web |title=Qualisure Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/qualisure-diagnostics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated